Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02659358 · ClinicalTrials.gov registry record
Evaluating the Use of Wearable Biosensors and PROs to Assess Performance Status in Patients With Cancer
A clinical trial, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- 37
- Enrollment target
NCT02659358 is a clinical trial that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 37 participants.
The verdict
NCT02659358 has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- 37 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the association between wearable biosensor data, performance status and patient-reported outcomes in cancer patients. Participants in this study will wear a biosensor (Fitbit Charge HR®) for 15 days and respond to questionnaires that will assess patient reported outcome measures including physical function, emotional distress, pain interference, sleep disturbance and fatigue. Eligible patients will have a diagnosis of advanced cancer. Patients must be greater than 18 years of age and be English speaking due to the questionnaires that will be administered during the study. Patients must also be ambulatory (use of walking aids, such as cane and rollator, is acceptable) and have access to a smartphone with internet access (IOS or Android). It is also necessary for patients to have scheduled oncology clinic visits at least once every 2 weeks.
Interventions
- DEVICE Fitbit Charge HR®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2016-01-24 |
| Est. Completion | 2017-08-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02659358
The ClinicalTrials.gov registry entry for NCT02659358 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fitbit Charge HR® is the first listed.
NCT02659358 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02659358 about?
NCT02659358 is a clinical study titled "Evaluating the Use of Wearable Biosensors and PROs to Assess Performance Status in Patients With Cancer". The purpose of this study is to evaluate the association between wearable biosensor data, performance status and patient-reported outcomes in cancer patients. Participants in this study will wear a biosensor (Fitbit Charge HR®) for 15 days and respond to questionnaires that will assess patient repor...
What is the current status of trial NCT02659358?
This trial is currently completed. The enrollment target is 37 participants. The study started on 2016-01-24. Estimated completion is 2017-08-24.
What interventions are being tested in trial NCT02659358?
The interventions under investigation include: Fitbit Charge HR® (DEVICE).
Who is sponsoring clinical trial NCT02659358?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.